Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index

Clinical and Experimental Optometry

Volumn 95, Issue 3, 2012, Pages 362-370

  Fenwick, Eva K ^a   Xie, Jing ^a   Pesudovs, Konrad ^b   Ratcliffe, Julie ^c   Chiang, Peggy P C ^d   Finger, Robert P ^a   Lamoureux, Ecosse L ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

Author keywords

Diabetes; Low vision; Retina; Retinopathy; Visual acuity

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RETINA MACULA EDEMA; VISUAL ACUITY; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; QUALITY OF LIFE; VISION DISORDERS; VISUAL ACUITY;

EID: 84861221129     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2012.00742.x     Document Type: Article

References (45)

1. Cheung N, Wong T. Diabetic retinopathy and systemic complications. In: Duh E, ed. Diabetic Retinopathy. New Jersey: Humana Press, 2009. p 465-482.
2. Wong T, Klein K. The epidemiology of eye diseases in diabetes. In: Ekoé J, Rewers M, Williams R, Zimmet P, eds. The Epidemiology of Diabetes Mellitus, 2nd ed. Oxford: John Wiley and Sons, 2008. p 475-497.
3. Cheung N, Mitchell P, Wong T. Diabetic retinopathy. Lancet 2010; 376: 124-136.
4. Fenwick E, Pesudovs K, Rees G, Dirani M, Kawasaki R, Wong T, Lamoureux E. The impact of diabetic retinopathy: understanding the patient's perspective. Br J Ophthalmol 2010; 95: 774-782.
5. Fenwick E, Rees G, Pesudovs K, Dirani M, Kawasaki R, Wong T, Lamoureux E. Social and emotional impact of diabetic retinopathy: a review. Clin Experiment Ophthalmol 2011; 40: 27-38.
6. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999; 128: 324-330.
7. Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 2002; 120: 481-484.
8. Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol 2002; 86: 493-496.
9. Sharma S, Oliver-Fernandez A, Bakal J, Hollands H, Brown GC, Brown MM. Utilities associated with diabetic retinopathy: results from a Canadian sample. Br J Ophthalmol 2003; 87: 259-261.
10. Shah VA, Gupta SK, Shah KV, Vinjamaram S, Chalam KV. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD. Ophthalmic Epidemiol 2004; 11: 43-51.
11. Huang ES, Brown SFS, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007; 30: 2478-2483.
12. Tung TH, Chen SJ, Lee FL, Liu JH, Lin CH, Chou P. A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract 2005; 68: 265-273.
13. Lee BS, Kymes SM, Nease RF, Sumner W, Siegfried CJ, Gordon MO. The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology 2008; 115: 898-903.
14. Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A. Health utility values associated with diabetic retinopathy. Diabet Med 2008; 25: 618-624.
15. Brazier JE, Ratcliffe J, Salomon J, Tsuchiya A. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford, UK: Oxford University Press, 2007.
16. Torrence G. Utility approach to measuring health-related quality of life. J Chronic Dis 1987; 40: 593-600.
17. Williams A. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
18. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI (R)) system for assessing health-related quality of life in clinical studies. Ann Med 2001; 33: 375-384.
19. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001; 33: 328-336.
20. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004; 42: 851-859.
21. Hawthorne G, Richardson J, Osborne R. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999; 8: 209-224.
22. Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications fromCODE-2 data. Health Econ 2005; 14: 217-230.
23. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002; 22: 340-349.
24. Smith DH, Johnson ES, Russell A, Hazlehurst B, Muraki C, Nichols GA, Oglesby A etal. Lower visual acuity predicts worse utility values among patients with type 2 diabetes. Qual Life Res 2008; 17: 1277-1284.
25. Langelaan M, de Boer M, van Nispen R, Wouters B, Moll A, van Rens G. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiol 2007; 14: 119-126.
26. Kontodimopoulos N, Pappa E, Chadjiapostolou Z, Arvanitaki E, Papadopoulos AA, Niakas D. Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications. Eur J Health Econ 2010; 13: 111-120.
27. Sakamaki H, Ikeda S, Ikegami N, Uchigata Y, Iwamoto Y, Origasa H, Otani T etal. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health 2006; 9: 47-53.
28. Glasziou P, Alexander J, Beller E, Clarke P, ADVANCE Collaborative Group. Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes 2007; 5: 21.
29. Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010; 8: 18.
30. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F etal. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011; 118: 615-625.
31. Fenwick E, Xie J, Ratcliffe R, Pesudovs K, Finger R, Wong T, Lamoureux E. The impact of diabetic retinopathy and diabetic macular oedema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci 2011; 53: 677-784.
32. Hays RD, Hahn H, Marshall G. Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities. Arch Phys Med Rehabil 2002; 83: S4-S9.
33. Brenner M, Curbow B, Legro MW. The proximal-distal continuum of multiple health outcomes measures: the case of cataract surgery. Med Care 1995; 33 (Suppl 4): AS236-AS244.
34. Hahl J, Hamalainen H, Sintonen H, Simell T, Arinen S, Simell O. Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Qual Life Res 2002; 11: 427-436.
35. Misajon R, Hawthorne G, Richardson J, Barton J, Peacock S, Iezzi A, Keeffe J. Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci 2005; 46: 4007-4015.
36. Peacock S, Misajon R, Iezzi A, Richardson J, Hawthorne G, Keeffe J. Vision and quality of life: development of methods for the VisQoL vision-related utility instrument. Ophthalmic Epidemiol 2008; 15: 218-223.
37. Lamoureux EL, Fenwick E, Xie J, Mcauley A, Nicolaou T, Larizza M, Rees G etal. Methodology and early findings of the Diabetes Management Project: a cohort study investigating the barriers to optimal diabetes care in diabetic patients with and without diabetic retinopathy Clin Experiment Ophthalmol 2012; 40: 73-82.
38. Wilkinson CP, Ferris III FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D etal. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-82.
39. Bharmal M, Thomas J. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value in Health 2006; 9: 262-271.
40. Buchinsky M. Recent advances in quantile regression models: a practical guideline for empirical research. J Human Resources 1998; 33: 88-126.
41. Ahola AJ, Saraheimo M, Forsblom C, Hietala K, Sintonen H, Groop PH. Health-related quality of life in patients with type 1 diabetes-association with diabetic complications (the FinDiane Study). Nephrol Dial Transplant 2010; 25: 1903-1908.
42. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001; 357: 7-8.
43. Bilbao A, Quintana JM, Escobar A, Garcia S, Andradas E, Bare M, Elizalde B. Responsiveness and clinically important differences for the VF-14 index, SF-36, and visual acuity in patients undergoing cataract surgery. Ophthalmology 2009; 116: 418-424.
44. Lamoureux EL, Pesudovs K. Vision-specific quality of life research: a need to improve the quality. Am J Ophthalmol 2011; 151: 195-197.
45. Kaplan RM, Tally S, Hays RD, Feeny D, Ganiats TG, Palta M, Fryback DG. Five preference-based indexes in cataract and heart failure patients were not equally responsive to change. J Clin Epidemiol 2010; 64: 497-506.